Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT06388421 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT06388421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Lead sponsor
United Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
January 23, 2025
Completion date
November 30, 2030
Enrollment
900 (estimated)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary hypertension, pulmonary hypertension due to lung diseases and hypoxia